Which of the following is not part of the baseline tests for patients on SSOR?

The correct response indicates that serum sodium is not part of the baseline tests for patients on Short Course Oral Regimen (SSOR) for tuberculosis. Baseline testing is critical to ensure the safety and efficacy of treatment, particularly when dealing with anti-TB medications that can have specific side effects or implications for liver function and overall health.

Baseline tests typically focus on monitoring liver function, which is why tests like AST (aspartate aminotransferase) and ALT (alanine aminotransferase) are performed, providing vital information regarding hepatic health before initiating therapy. Additionally, ECG (electrocardiogram) may be included to assess cardiac health, particularly in patients who might be at risk of cardiac side effects from certain TB medications.

DST (Drug Susceptibility Testing) and LPA (Line Probe Assay) are both test types that directly assess the bacteria causing the infection, checking their resistance to specific TB drugs. These tests are essential in guiding effective treatment plans.

In contrast, while serum sodium is important in evaluating a patient's electrolyte balance and general health, it is not typically included among the baseline tests specifically associated with monitoring the impact of SSOR treatments for tuberculosis. This distinction underscores the focus of TB treatment protocols on liver function and drug